A. Jo Chien, MD

Stanford University, Stanford, CA, BS w/ Honors, 1998, Biological Sciences
Harvard Medical School, Boston, MA, MD, 2003

• 2003-2004
  Intern, Internal Medicine, Massachusetts General Hospital, Boston, MA
• 2004-2006
  Resident, Internal Medicine, Massachusetts General Hospital, Boston, MA
• 2006-2009
  Fellow, Hematology and Oncology, UCSF, San Francisco, CA
• 2007-2009
  Chief Fellow, Hematology and Oncology, UCSF, San Francisco, CA

• 1994
  Robert C. Byrd California State Scholarship
• 1994
  Stanford University Presidential Scholar
• 1996
  Howard Hughes Undergraduate Research Grant
• 1998
  Phi Beta Kappa Society Electee
• 1998
  Stanford University Department of Biological Sciences Graduate of Distinction
• 2003
  Massachusetts Medical Society and Alliance Charitable Foundation International Health Grant
• 2008
  ASCO Young Investigator Award
• 2008
  ASCO Foundation Merit Award
• 2008
  American Cancer Society Postdoctoral Fellowship

• Chien, AJ, Goss, PE. Aromatase Inhibitors and bone health in women with breast cancer, Journal of Clinical Oncology. 2006 Nov 20;24(33):5305-12.
• Chien, AJ, Moasser, MM. Cellular Mechanisms of Resistance to Anthracyclines and Taxanes: Intrinsic and Acquired, Seminars in Oncology. 2008 Apr;35(2 Suppl 2):S1-S14; quiz S39.
• Chien, AJ, Illi, J, Ko, AH, Korn WM, Fong L, Chen LM, Kashani-Sabet M,Ryan C, Rosenberg J, Dubey S, Small EJ, Jahan TM, H ylton NM, Yeh BM, Huang Y, Koch KM, Moasser MM. A phase 1 study of a 2 day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound paclitaxel for advanced solid malignancies, Clinical Cancer Research. 2009 Sept 1;15(17):5569-75.
• Chien, AJ, Rugo, HS. Lapatinib: New Directions in HER2 Directed Therapy in Early Stage Breast Cancer, Cancer Treat Res. 2009;151:197-215.